🔎 Trials Near Me

Home › Mga Autoimmune na Sakit › Pennsylvania

Pag-aaral pangklinika para sa Mga Autoimmune na Sakit sa Pennsylvania

22 pag-aaral para sa Mga Autoimmune na Sakit ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
  • UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients, Pittsburgh
  • UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients, Pittsburgh
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

  • University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology, Pittsburgh
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07103746

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  • The Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06056297

Study of PTC844 in Participants With Active Rheumatoid Arthritis

  • Rheumatology Specialty Center, Willow Grove
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07779616

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06948318

Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases

  • Lewis Katz School of Medicine at Temple University, Philadelphia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06626919

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • Children's Hospital of Philadelphia - Accepting Young Adult and Adolescent Patients, Philadelphia
Nagre-recruitPhase 1/2
Edad 12 hanggang 65 · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT06121297

Autoimmunity After Checkpoint Blockade

  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04119713

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

  • Fox Chase Cancer Center- Temple BMT, Philadelphia
Nagre-recruitPhase 2
Edad 16 hanggang 70 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07328581

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Philadelphia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06572384

Abatacept for the Treatment of Giant Cell Arteritis

  • University of Pennsylvania, Philadelphia
Nagre-recruitPhase 3
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT04474847

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  • Thomas Jefferson University Hospital, Philadelphia
Nagre-recruitPhase 2/3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Penn State Milton S. Hershey Cancer Center, Hershey
  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh, Pittsburgh
  • at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • Jefferson Einstein Hospital Philadelphia, Philadelphia
Nagre-recruitPhase 1
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting

  • Magee-Womens Hospital, Pittsburgh
Nagre-recruit
Lahat ng edad · Kalalakihan · Na-update Abr 22, 2026 · NCT04452305

Testicular Tissue Cryopreservation for Fertility Preservation

  • Magee-Womens Hospital, Pittsburgh
Nagre-recruit
Lahat ng edad · Kalalakihan · Na-update Abr 22, 2026 · NCT02972801

Ovarian Tissue Cryopreservation for Fertility Preservation

  • Magee-Womens Hospital, Pittsburgh
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 39 · Kababaihan · Na-update Mar 4, 2026 · NCT05875155

Central Vein Sign in Multiple Sclerosis Extension Study

  • University of Pennsylvania, Philadelphia
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT07424027

X-linked Moesin Associated Immunodeficiency

  • Perelman School of medecine, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
Edad 4 hanggang 80 · Kalalakihan · Na-update Abr 25, 2025 · NCT06278337

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.